Abstract
Oral lichen planus (OLP) is a common T cell-mediated chronic inflammatory disease with malignant potential and unclear etiology. The present study suggests that antigen-specific mechanisms in which dentritic cells, T lymphocytes and NF-κB signaling pathway play critical roles, are involved in the pathogenesis of OLP. Additionally, it has been indicated that altered expression of cyclooxygenase 2 (COX-2) and imbalanced oxidant-antioxidant status as well as psychological issue may act as promoters to the development of OLP. Therapies for OLP are primarily aimed to control symptoms and a specific cure is not yet available. Black pepper and its principle bioactive compound piperine have been reported to possess remarkable pharmacological activities. Not only has piperine been evidenced to exhibit repressive effects on the maturation of dentritic cells, the proliferation, activation and function of T lymphocytes as well as the NF-κB signaling pathway, but also to suppress the overproduction of COX-2 and weaken the oxidative stress. Furthermore, piperine might be a possible agent for alleviating psychological disorders and preventing carcinogenesis. Given all these into consideration, piperine may be a novel and effective therapeutic strategy for OLP.
Similar content being viewed by others
References
Abdel HRM, Fawzy MM, Metwally D et al (2012) DNA polymorphisms and tissue cyclooxygenase-2 expression in oral lichen planus: a case–control study. J Eur Acad Dermatol Venereol 26(9):1122–1126
Abdolsamadi H, Rafieian N, Goodarzi MT et al (2014) Levels of salivary antioxidant vitamins and lipid peroxidation in patients with oral lichen planus and healthy individuals. Chonnam Med J. 50(2):58–62
Agha-Hosseini F, Mirzaii-Dizgah I, Mikaili S, Abdollahi M (2009) Increased salivary lipid peroxidation in human subjects with oral lichen planus. Int J Dent Hyg. 7(4):246–250
Alrashdan MS, Cirillo N, McCullough M (2016) Oral lichen planus: a literature review and update. Arch Dermatol Res 308(8):539–551
Alshahrani S, Baccaglini L (2014) Psychological screening test results for stress, depression, and anxiety are variably associated with clinical severity of recurrent aphthous stomatitis and oral lichen planus. J Evid Based Dent Pract. 14(4):206–208
Alves MG, Do Carmo Carvalho BF, Balducci I, Cabral LA, Nicodemo D, Almeida JD (2015) Emotional assessment of patients with oral lichen planus. Int J Dermatol 54(1):29–32
Amirchaghmaghi M, Hashemy SI, Alirezaei B et al (2016) Evaluation of plasma isoprostane in patients with oral lichen planus. J Dent (Shiraz). 17(1):21–25
Azizi A, Farshchi F (2012) Comparison of salivary and plasma antioxidant levels in lichen planus patients and healthy subjects. J Oral Pathol Med 41(7):524–526
Bae GS, Kim MS, Jung WS et al (2010) Inhibition of lipopolysaccharide-induced inflammatory responses by piperine. Eur J Pharmacol 642(1–3):154–162
Bae GS, Kim JJ, Park KC et al (2012) Piperine inhibits lipopolysaccharide-induced maturation of bone-marrow-derived dendritic cells through inhibition of ERK and JNK activation. Phytother Res. 26(12):1893–1897
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow. Lancet 357(9255):539–545
Bang JS, Oh DH, Choi HM et al (2009) Anti-inflammatory and antiarthritic effects of piperine in human interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat arthritis models. Arthritis Res Ther. 11(2):R49
Barrett AW, Cruchley AT, Williams DM (1996) Oral mucosal Langerhans’ cells. Crit Rev Oral Biol Med 7(1):36–58
Battino M, Greabu M, Totan A et al (2008) Oxidative stress markers in oral lichen planus. BioFactors 33(4):301–310
Bayer AL, Pugliese A, Malek TR (2013) The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation. Immunol Res 57(1–3):197–209
Buczko P, Zalewska A, Szarmach I (2015) Saliva and oxidative stress in oral cavity and in some systemic disorders. J Physiol Pharmacol 66(1):3–9
Butt MS, Pasha I, Sultan MT, Randhawa MA, Saeed F, Ahmed W (2013) Black pepper and health claims: a comprehensive treatise. Crit Rev Food Sci Nutr 53(9):875–886
Chen Y, Zhang W, Geng N, Tian K, Jack WL (2008) MMPs, TIMP-2, and TGF-beta1 in the cancerization of oral lichen planus. Head Neck 30(9):1237–1245
Chuchawankul S, Khorana N, Poovorawan Y (2012) Piperine inhibits cytokine production by human peripheral blood mononuclear cells. Genet Mol Res 11(1):617–627
Cortés-Ramírez DA, Rodríguez-Tojo MJ, Gainza-Cirauqui ML, Martínez-Conde R, Aguirre-Urizar JM (2010) Overexpression of cyclooxygenase-2 as a biomarker in different subtypes of the oral lichenoid disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110(6):738–743
Crincoli V, Di BMB, Scivetti M, Lucchese A, Tecco S, Festa F (2011) Oral lichen planus: update on etiopathogenesis, diagnosis and treatment. Immunopharmacol Immunotoxicol 33(1):11–20
Danielsson K, Ebrahimi M, Wahlin YB, Nylander K, Boldrup L (2012) Increased levels of COX-2 in oral lichen planus supports an autoimmune cause of the disease. J Eur Acad Dermatol Venereol 26(11):1415–1419
Darczuk D, Krzysciak W, Vyhouskaya P et al (2016) Salivary oxidative status in patients with oral lichen planus. J Physiol Pharmacol 67(6):885–894
Deng Y, Sriwiriyajan S, Tedasen A, Hiransai P, Graidist P (2016) Anti-cancer effects of Piper nigrum via inducing multiple molecular signaling in vivo and in vitro. J Ethnopharmacol 188:87–95
Derosa G, Maffioli P, Sahebkar A (2016) Piperine and its role in chronic diseases. Adv Exp Med Biol 928:173–184
Doucette CD, Greenshields AL, Liwski RS, Hoskin DW (2015a) Piperine blocks interleukin-2-driven cell cycle progression in CTLL-2 T lymphocytes by inhibiting multiple signal transduction pathways. Toxicol Lett 234(1):1–12
Doucette CD, Rodgers G, Liwski RS, Hoskin DW (2015b) Piperine from black pepper inhibits activation-induced proliferation and effector function of T lymphocytes. J Cell Biochem 116(11):2577–2588
Edwards PC, Kelsch R (2002) Oral lichen planus: clinical presentation and management. J Can Dent Assoc 68(8):494–499
El-Rifaie AA, Rashed LA, Doss RW (2015) The role of cyclooxygenase-2 and prostaglandin E2 in the pathogenesis of cutaneous lichen planus. Clin Exp Dermatol 40(8):903–907
Farthing PM, Matear P, Cruchley AT (1990) The activation of Langerhans cells in oral lichen planus. J Oral Pathol Med 19(2):81–85
Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C (2007) Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 121(11):2381–2386
Fitzpatrick SG, Hirsch SA, Gordon SC (2014) The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc 145(1):45–56
Gavic L, Cigic L, Biocina LD, Gruden V, Gruden PJS (2014) The role of anxiety, depression, and psychological stress on the clinical status of recurrent aphthous stomatitis and oral lichen planus. J Oral Pathol Med 43(6):410–417
Girardi C, Luz C, Cherubini K, de Figueiredo MA, Nunes ML, Salum FG (2011) Salivary cortisol and dehydroepiandrosterone (DHEA) levels, psychological factors in patients with oral lichen planus. Arch Oral Biol 56(9):864–868
Hritcu L, Noumedem JA, Cioanca O, Hancianu M, Postu P, Mihasan M (2015) Anxiolytic and antidepressant profile of the methanolic extract of Piper nigrum fruits in beta-amyloid (1-42) rat model of Alzheimer’s disease. Behav Brain Funct 11:13
Huang W, Chen Z, Wang Q et al (2013) Piperine potentiates the antidepressant-like effect of trans-resveratrol: involvement of monoaminergic system. Metab Brain Dis 28(4):585–595
Hwang YP, Yun HJ, Kim HG et al (2011) Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2-dependent matrix metalloproteinase-9 expression. Toxicol Lett 203(1):9–19
Ivanovski K, Nakova M, Warburton G et al (2005) Psychological profile in oral lichen planus. J Clin Periodontol 32(10):1034–1040
Jungell P (1991) Oral lichen planus. A review. Int J Oral Maxillofac Surg. 20(3):129–135
Kannan A, Huang W, Huang F, August A (2012) Signal transduction via the T cell antigen receptor in naïve and effector/memory T cells. Int J Biochem Cell Biol 44(12):2129–2134
Kawanishi S, Hiraku Y, Pinlaor S, Ma N (2006) Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 387(4):365–372
Kesarwala AH, Krishna MC, Mitchell JB (2016) Oxidative stress in oral diseases. Oral Dis 22(1):9–18
Khom S, Strommer B, Schöffmann A et al (2013) GABAA receptor modulation by piperine and a non-TRPV1 activating derivative. Biochem Pharmacol 85(12):1827–1836
Kim HG, Han EH, Jang WS et al (2012) Piperine inhibits PMA-induced cyclooxygenase-2 expression through downregulating NF-κB, C/EBP and AP-1 signaling pathways in murine macrophages. Food Chem Toxicol 50(7):2342–2348
Koleva II, van Beek TA, Soffers AE, Dusemund B, Rietjens IM (2012) Alkaloids in the human food chain–natural occurrence and possible adverse effects. Mol Nutr Food Res 56(1):30–52
Kong LD, Cheng CH, Tan RX (2004) Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. J Ethnopharmacol 91(2–3):351–355
Koray M, Dülger O, Ak G et al (2003) The evaluation of anxiety and salivary cortisol levels in patients with oral lichen planus. Oral Dis 9(6):298–301
Kumar S, Singhal V, Roshan R, Sharma A, Rembhotkar GW, Ghosh B (2007) Piperine inhibits TNF-alpha induced adhesion of neutrophils to endothelial monolayer through suppression of NF-kappaB and IkappaB kinase activation. Eur J Pharmacol 575(1–3):177–186
Lai LH, Fu QH, Liu Y et al (2012) Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacol Sin 33(4):523–530
Lee SA, Hong SS, Han XH et al (2005) Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity. Chem Pharm Bull (Tokyo). 53(7):832–835
Lee SH, Kim HY, Back SY, Han HK (2018) Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives. Expert Opin Drug Metab Toxicol. 14(1):43–57
Li TJ, Cui J (2013) COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma. Asian Pac J Trop Med. 6(8):640–643
Li S, Wang C, Li W, Koike K, Nikaido T, Wang MW (2007a) Antidepressant-like effects of piperine and its derivative, antiepilepsirine. J Asian Nat Prod Res 9(3–5):421–430
Li S, Wang C, Wang M, Li W, Matsumoto K, Tang Y (2007b) Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms. Life Sci 80(15):1373–1381
Liu Y, Yadev VR, Aggarwal BB, Nair MG (2010) Inhibitory effects of black pepper (Piper nigrum) extracts and compounds on human tumor cell proliferation, cyclooxygenase enzymes, lipid peroxidation and nuclear transcription factor-kappa-B. Nat Prod Commun 5(8):1253–1257
Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K (2005) Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 100(1):40–51
Lu R, Zhou G, Du G, Xu X, Yang J, Hu J (2011) Expression of T-bet and GATA-3 in peripheral blood mononuclear cells of patients with oral lichen planus. Arch Oral Biol 56(5):499–505
Lu R, Zhang J, Sun W, Du G, Zhou G (2015) Inflammation-related cytokines in oral lichen planus: an overview. J Oral Pathol Med 44(1):1–14
Lu Y, Liu J, Li H, Gu L (2016) Piperine ameliorates lipopolysaccharide-induced acute lung injury via modulating NF-κB signaling pathways. Inflammation. 39(1):303–308
Lundqvist EN, Wahlin YB, Bergdahl M, Bergdahl J (2006) Psychological health in patients with genital and oral erosive lichen planus. J Eur Acad Dermatol Venereol 20(6):661–666
Lysitsa S, Samson J, Gerber-Wicht C, Lang U, Lombardi T (2008) COX-2 expression in oral lichen planus. Dermatology 217(2):150–155
Manayi A, Nabavi SM, Setzer WN, Jafari S (2017) Piperine as a potential anti-cancer agent: a review on preclinical studies. Curr Med Chem. https://doi.org/10.2174/0929867324666170523120656
Mao QQ, Xian YF, Ip SP, Che CT (2011) Involvement of serotonergic system in the antidepressant-like effect of piperine. Prog Neuropsychopharmacol Biol Psychiatry 35(4):1144–1147
Mao QQ, Huang Z, Zhong XM, Xian YF, Ip SP (2014a) Brain-derived neurotrophic factor signalling mediates the antidepressant-like effect of piperine in chronically stressed mice. Behav Brain Res 261:140–145
Mao QQ, Huang Z, Zhong XM, Xian YF, Ip SP (2014b) Piperine reverses chronic unpredictable mild stress-induced behavioral and biochemical alterations in rats. Cell Mol Neurobiol 34(3):403–408
Maraskovsky E, Chen WF, Shortman K (1989) IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. J Immunol. 143(4):1210–1214
Meghwal M, Goswami TK (2013) Piper nigrum and piperine: an update. Phytother Res. 27(8):1121–1130
Mignogna MD, Fedele S, Lo RL, Lo ML, Bucci E (2004) Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence. Oral Oncol 40(2):120–130
Misra S, Sharma K (2014) COX-2 signaling and cancer: new players in old arena. Curr Drug Targets 15(3):347–359
Mittal R, Gupta RL (2000) In vitro antioxidant activity of piperine. Methods Find Exp Clin Pharmacol 22(5):271–274
Myers LK, Kang AH, Postlethwaite AE et al (2000) The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum 43(12):2687–2693
Nadendla LK, Meduri V, Paramkusam G, Pachava KR (2014) Association of salivary cortisol and anxiety levels in lichen planus patients. J Clin Diagn Res. 8(12):ZC01–ZC03
Nagler RM, Klein I, Zarzhevsky N, Drigues N, Reznick AZ (2002) Characterization of the differentiated antioxidant profile of human saliva. Free Radic Biol Med. 32(3):268–277
Nogueira PA, Carneiro S, Ramos-e-Silva M (2015) Oral lichen planus: an update on its pathogenesis. Int J Dermatol 54(9):1005–1010
Payeras MR, Cherubini K, Figueiredo MA, Salum FG (2013) Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol 58(9):1057–1069
Peng Q, Zhang J, Ye X, Zhou G (2017) Tumor-like microenvironment in oral lichen planus: evidence of malignant transformation. Expert Rev Clin Immunol. 13(6):635–643
Pippi R, Patini R, Ghiciuc CM et al (2014) Diurnal trajectories of salivary cortisol, salivary α-amylase and psychological profiles in oral lichen planus patients. J Biol Regul Homeost Agents 28(1):147–156
Pippi R, Romeo U, Santoro M, Del VA, Scully C, Petti S (2016) Psychological disorders and oral lichen planus: matched case-control study and literature review. Oral Dis 22(3):226–234
Pradeep CR, Kuttan G (2004) Piperine is a potent inhibitor of nuclear factor-kappaB (NF-kappaB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. Int Immunopharmacol 4(14):1795–1803
Prolo P, Chiappelli F, Cajulis E et al (2002) Psychoneuroimmunology in oral biology and medicine: the model of oral lichen planus. Ann N Y Acad Sci 966:429–440
Rauscher FM, Sanders RA, Watkins JB (2000) Effects of piperine on antioxidant pathways in tissues from normal and streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 14(6):329–334
Rekha VR, Sunil S, Rathy R (2017) Evaluation of oxidative stress markers in oral lichen planus. J Oral Maxillofac Pathol. 21(3):387–393
Rodgers G, Doucette CD, Soutar DA, Liwski RS, Hoskin DW (2016) Piperine impairs the migration and T cell-activating function of dendritic cells. Toxicol Lett 242:23–33
Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010) Pathogenesis of oral lichen planus–a review. J Oral Pathol Med 39(10):729–734
Scrobotă I, Mocan T, Cătoi C, Bolfă P, Mureşan A, Băciuţ G (2011) Histopathological aspects and local implications of oxidative stress in patients with oral lichen planus. Rom J Morphol Embryol 52(4):1305–1309
Sezer E, Ozugurlu F, Ozyurt H, Sahin S, Etikan I (2007) Lipid peroxidation and antioxidant status in lichen planus. Clin Exp Dermatol 32(4):430–434
Shah B, Ashok L, Sujatha GP (2009) Evaluation of salivary cortisol and psychological factors in patients with oral lichen planus. Indian J Dent Res. 20(3):288–292
Shirzad A, Pouramir M, Seyedmajidi M, Jenabian N, Bijani A, Motallebnejad M (2014) Salivary total antioxidant capacity and lipid peroxidation in patients with erosive oral lichen planus. J Dent Res Dent Clin Dent Prospects. 8(1):35–39
Singh P, Grover J, Byatnal AA, Guddattu V, Radhakrishnan R, Solomon MC (2017) Elucidating the role of Cyclooxygenase-2 in the pathogenesis of oral lichen planus—an immunohistochemical study with supportive histochemical analysis. J Oral Pathol Med 46(5):381–386
Sloberg K, Jonsson R, Jontell M (1984) Assessment of Langerhans’ cells in oral lichen planus using monoclonal antibodies. J Oral Pathol 13(5):516–524
Smith WL, Garavito RM, DeWitt DL (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271(52):33157–33160
Srinivasan K (2007) Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Crit Rev Food Sci Nutr 47(8):735–748
Sugerman PB, Satterwhite K, Bigby M (2000) Autocytotoxic T-cell clones in lichen planus. Br J Dermatol 142(3):449–456
Sugerman PB, Savage NW, Walsh LJ et al (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13(4):350–365
Suzuki J, Ogawa M, Futamatsu H, Kosuge H, Tanaka H, Isobe M (2006) A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats. J Mol Cell Cardiol 40(5):688–695
Tadakamadla J, Kumar S, Lalloo R, Johnson NW (2017) Qualitative analysis of the impact of oral potentially malignant disorders on daily life activities. PLoS One 12(4):e0175531
Tvarijonaviciute A, Aznar-Cayuela C, Rubio CP, Ceron JJ, López-Jornet P (2017) Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome. J Oral Pathol Med 46(5):387–392
Uma PK, Geervani P, Eggum BO (1993) Common Indian spices: nutrient composition, consumption and contribution to dietary value. Plant Foods Hum Nutr 44(2):137–148
Upadhyay RB, Carnelio S, Shenoy RP, Gyawali P, Mukherjee M (2010) Oxidative stress and antioxidant defense in oral lichen planus and oral lichenoid reaction. Scand J Clin Lab Invest 70(4):225–228
Upadhyay J, Upadhyay RB, Agrawal P, Jaitley S, Shekhar R (2013) Langerhans cells and their role in oral mucosal diseases. N Am J Med Sci. 5(9):505–514
Vaibhav K, Shrivastava P, Javed H et al (2012) Piperine suppresses cerebral ischemia-reperfusion-induced inflammation through the repression of COX-2, NOS-2, and NF-κB in middle cerebral artery occlusion rat model. Mol Cell Biochem 367(1–2):73–84
Vallejo MJ, Huerta G, Cerero R, Seoane JM (2001) Anxiety and depression as risk factors for oral lichen planus. Dermatology 203(4):303–307
van der Waal I (2009) Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol 45(4–5):317–323
Vardell E (2015) Natural Medicines: a Complementary and Alternative Medicines Tool Combining Natural Standard and the Natural Medicines Comprehensive Database. Med Ref Serv Q. 34(4):461–470
Verma A, Kushwaha HN, Srivastava AK et al (2017) Piperine attenuates UV-R induced cell damage in human keratinocytes via NF-kB, Bax/Bcl-2 pathway: an application for photoprotection. J Photochem Photobiol, B 172:139–148
Vijayakumar RS, Surya D, Nalini N (2004) Antioxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress. Redox Rep. 9(2):105–110
Vlková B, Stanko P, Minárik G et al (2012) Salivary markers of oxidative stress in patients with oral premalignant lesions. Arch Oral Biol 57(12):1651–1656
Wattanathorn J, Chonpathompikunlert P, Muchimapura S, Priprem A, Tankamnerdthai O (2008) Piperine, the potential functional food for mood and cognitive disorders. Food Chem Toxicol 46(9):3106–3110
Ying X, Chen X, Cheng S, Shen Y, Peng L, Xu HZ (2013a) Piperine inhibits IL-β induced expression of inflammatory mediators in human osteoarthritis chondrocyte. Int Immunopharmacol 17(2):293–299
Ying X, Yu K, Chen X et al (2013b) Piperine inhibits LPS induced expression of inflammatory mediators in RAW 264.7 cells. Cell Immunol. 285(1–2):49–54
Zaugg J, Baburin I, Strommer B, Kim HJ, Hering S, Hamburger M (2010) HPLC-based activity profiling: discovery of piperine as a positive GABA(A) receptor modulator targeting a benzodiazepine-independent binding site. J Nat Prod 73(2):185–191
Zhai WJ, Zhang ZB, Xu NN et al (2016) Piperine plays an anti-inflammatory role in staphylococcus aureus endometritis by inhibiting activation of NF-κB and MAPK pathways in mice. Evid Based Complement Alternat Med. 2016:8597208
Zhang L, Bertucci AM, Smith KA, Xu L, Datta SK (2007) Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus. Arthritis Rheum 56(12):4132–4141
Zhang J, Zhu X, Li H et al (2015) Piperine inhibits proliferation of human osteosarcoma cells via G2/M phase arrest and metastasis by suppressing MMP-2/-9 expression. Int Immunopharmacol 24(1):50–58
Zhou XJ, Sugerman PB, Savage NW, Walsh LJ (2001) Matrix metalloproteinases and their inhibitors in oral lichen planus. J Cutan Pathol 28(2):72–82
Zhou G, Xia K, Du GF et al (2009) Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: a clinicopathologic study in atrophic-erosive and reticular form. J Oral Pathol Med 38(7):559–564
Zhou G, Zhang J, Ren XW, Hu JY, Du GF, Xu XY (2012) Increased B7-H1 expression on peripheral blood T cells in oral lichen planus correlated with disease severity. J Clin Immunol 32(4):794–801
Acknowledgement
This work was supported by grants from the National Natural Science Foundation of China (nos. 81771080, 81371147) to Gang Zhou.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflict of interest regarding the publication of this paper.
Rights and permissions
About this article
Cite this article
Yang, JY., Zhang, J. & Zhou, G. Black pepper and its bioactive constituent piperine: promising therapeutic strategies for oral lichen planus. Inflammopharmacol 27, 5–13 (2019). https://doi.org/10.1007/s10787-018-0540-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-018-0540-7